Dr. B. Robert Mozayeni is an internist, rheumatologist, and medical scientist. He is also an expert in translational medicine - advancing medical science safely and efficiently into medical practice. Dr. Mozayeni has practiced medicine for more than 30 years, specializing in the evaluation and treatment of inflammatory diseases, especially treatment-resistant autoimmune patients. He has special research and clinical expertise on an aspect of inflammation related to persistent infection and its relation to vascular physiology. He is a member of the American College of Physicians and previously, a Fellow of the American College of Rheumatology.

Dr. Mozayeni has published papers on immunology, inflammation, and cerebrovascular blood flow hemodynamics. He has presented his work at numerous US and international conferences. He holds over eight US and international patents. Dr. Mozayeni is an internationally recognized expert on the research and treatment of patients with various inflammatory and auto-immune features in whom a persistent infection, such as Bartonella, may be a root cause or contributing factor to be considered in the diagnostic assessment and treatment plan.

Dr. Mozayeni has been a past President of the International Lyme and Associated Diseases Society, where his goal was to help organize and educate practitioners in the translational medical science related to complex inflammatory syndromes. He is a Fellow of the nonprofit, Thought Leadership and Innovation Foundation, and a co-founder of the nonprofit Foundation for the Study of Inflammatory Diseases. 

In late 2019, Dr. Mozayeni founded T Lab, a research and clinical services laboratory developing and delivering advanced microscopy using RNA probes to support precision medicine in the care of individual patients with inflammatory conditions. He has held clinical privileges on the staff of Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the National Institutes of Health (NIH) Clinical Center, and previously, had been on the staff of the NIH Clinical Center and Yale-New Haven Hospital.

Dr. Mozayeni received his M.D. at Albany Medical College, where he developed his immunology research interest in the Transplantation Immunology Laboratory under the mentorship of Dr. Brian Freed, PhD and at the NIH as a Howard Hughes Research Scholar. After graduating with honors, he pursued his clinical medical training at Yale and later, the NIH. At Yale, he completed an Internal Medicine Residency, a Fellowship in Rheumatology, and a Post-doctoral Fellowship in Molecular Biophysics & Biochemistry, with a focus on the molecular basis of autoimmune diseases. He returned to NIH as a Senior Staff Fellow in the National Heart Lung and Blood Institute and a with a clinical appointment as Rheumatology Fellow in the National Institute of Arthritis and Musculoskeletal Diseases and the NIH Clinical Center. 

Dr. Mozayeni’s research career has centered around a passion to develop the medical science needed to enable the selective modulation of the immune response for transplantation, vaccine development, and autoimmune diseases. He is, therefore, excited to help the RheumaGen team and to be working again with Dr. Brian Freed, his first research mentor, to develop new and potentially curative treatments for the patients whom he has dedicated his career to serving – particularly those with complex and treatment-resistant autoimmune disorders.